QuickProfile Cancer Markers
Various cancers (e.g., via PSA, CEA)
CommercialActive
Key Facts
Indication
Various cancers (e.g., via PSA, CEA)
Phase
Commercial
Status
Active
Company
About LumiQuick Diagnostics
LumiQuick Diagnostics is a commercial-stage, private diagnostics company offering a diverse portfolio of rapid lateral flow tests and ELISA kits. Its product lines target human health (infectious diseases, cardiac markers, fertility, drugs of abuse), veterinary/food safety, and environmental/biothreat detection, leveraging a core immunochromatography technology platform. The company has achieved commercial traction, notably with an FDA EUA for its Boson Rapid SARS-CoV-2 Antigen Home Test, and operates in a competitive but expansive global rapid diagnostics market. Its strategy involves broadening its test menu and leveraging its QuickProfile and EnviroSafe brands across multiple sectors.
View full company profile